Related references
Note: Only part of the references are listed.Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients
N. Kamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad Implementation
Robert A. Montgomery et al.
TRANSPLANTATION (2009)
A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation
Gunnar Tyden et al.
TRANSPLANTATION (2009)
Vienna experience of ABO-incompatible living-donor kidney transplantation
Michael Haidinger et al.
WIENER KLINISCHE WOCHENSCHRIFT (2009)
Banff 07 classification of renal allograft pathology: Updates and future directions
K. Solez et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients
Shellee A. Grim et al.
CLINICAL TRANSPLANTATION (2007)
ABO-incompatible kidney transplantation-proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titers
Jochen Wilpert et al.
JOURNAL OF CLINICAL APHERESIS (2007)
ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment
G Nordén et al.
XENOTRANSPLANTATION (2006)
ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience
J Donauer et al.
XENOTRANSPLANTATION (2006)
Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan
K Takahashi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Plasma exchange conditioning for ABO-incompatible renal transplantation
JL Winters et al.
JOURNAL OF CLINICAL APHERESIS (2004)
Share Paper
